The stock price performance this year has been a mixed bag, which means people have different opinions about whether it’s been good or bad. Some may see it as optimistic, while others may view it as pessimistic. This year’s metric has recorded a Price increase of 256.88%. However, over the past six months, we’ve seen a weaker performance of 296.86%. The price of IMAB fallen by 82.63% over the last 30 days. And in the last five days, it has surged by 32.76%.
Currently, the stock price of I-Mab ADR (IMAB) is $3.89. In the most recent trading session, the stock underwent a significant upswing, peaking at $7.0 after opening at $3.89. The stock touched a low of $5.0 before closing at $3.41.
The market performance of I-Mab ADR has been somewhat stable. Over the past year, the company’s stock achieved a high of $4.18 on 08/07/25, with the lowest value for the same timeframe being $0.60, recorded on 04/04/25.
52-week price history of IMAB Stock
The history of a stock’s 52-week high and low prices can provide important information about its current state and future potential. I-Mab ADR’s current trading price is -6.94% away from its 52-week high, while its distance from the 52-week low is 553.78%. The stock’s price range for this period has been between $0.60 and $4.18. The Healthcare sector company’s shares saw a trading volume of about 2.85 million for the day, which was higher than the average daily volume of 1.57 million over the last three months.
The Connection Between Financial Performance and Market Capitalization
I-Mab ADR (IMAB) has experienced a quarterly rise of 342.05% in its revenues when compared to the same period in the previous year. Presently, the company has a total market capitalization of 307.08M and boasts a workforce of 32 employees.
Expert Opinions: Analysts’ Ratings for I-Mab ADR
As of right now, 3 analysts are rating I-Mab ADR as a BUY, 2 of the polled analysts branded the stock as an OVERWEIGHT, 0 analyst is recommending to HOLD this stock, 0 of them gave the stock UNDERWEIGHT rating, and 0 analyst is rating the stock as SELL.
How Moving Averages and Trading Volume Data Work Together
Based on Barchart.com data, the company’s moving average over the 100-day period was 1.62, with a change in price of +3.04. Similarly, I-Mab ADR recorded 1,084,420 in trading volume during the last 100 days, posting a change of +357.65%.
IMAB’s Debt-to-Equity Ratio: A Comprehensive Review
A key metric for assessing a company’s financial well-being and market status is the debt-to-equity (D/E) ratio. This ratio is derived by dividing a company’s total liabilities by its shareholders’ equity, and it demonstrates the level of debt a company uses to support its assets relative to shareholder equity. At the time of writing, the total D/E ratio for IMAB stands at 0.02. Similarly, the long-term debt-to-equity ratio is also 0.01.
IMAB Stock Stochastic Average
As of today, the raw stochastic average of I-Mab ADR over the last 50 days is at 90.27%. This shows a increasee from the raw stochastic average of the previous 20 days, which was recorded at 88.54%. Further, the company’s Stochastic %K and %D values for the last 20 days were 77.21% and 79.44%, respectively.
